Evaluation of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based VITEK MS System for the Identification of Acinetobacter Species from Blood Cultures: Comparison with VITEK 2 and MicroScan Systems
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Acinetobacter species are the leading cause of bloodstream infection (BSI), but their correct identification is challenging. We evaluated the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)-based VITEK MS (bioMérieux, France), and two automated systems, VITEK 2 (bioMérieux) and MicroScan (Siemens, USA) for identification of Acinetobacter BSI isolates. Methods: A total of 187 BSI isolates recovered at a university hospital in Korea between 2010 and 2012 were analyzed. The identification results obtained using VITEK MS and two automated systems were compared with those of rpoB sequencing. Results: Of 187 isolates analyzed, 176 were identified to the species level by rpoB sequencing: the Acinetobacter baumannii group (ABG; 101 A. baumannii, 43 A. nosocomialis, 10 A. pittii isolates) was most commonly identified (82.4%), followed by Acinetobacter genomic species 13BJ/14TU (5.3%), A. ursingii (2.1%), A. soli (2.1%), A. bereziniae (1.1%), and A. junii (1.1%). Correct identification rates to the species group (ABG) level or the species level was comparable among the three systems (VITEK MS, 90.3%; VITEK 2, 89.2%; MicroScan, 86.9%). However, VITEK MS generated fewer misidentifications (0.6%) than VITEK 2 (10.8%) and MicroScan (13.1%) (P<0.001). In addition, VITEK MS demonstrated higher specificity (100%) for discrimination between ABG and non-ABG isolates than the other systems (both, 31.8%) (P<0.001). Conclusions: The VITEK MS system is superior to the VITEK 2 and MicroScan systems for identification of Acinetobacter BSI isolates, with fewer misidentifications and better discrimination between the ABG and non-ABG isolates.
Abstract
Background: Acinetobacter species are the leading cause of bloodstream infection (BSI), but their correct identification is challenging. We evaluated the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)-based VITEK MS (bioMérieux, France), and two automated systems, VITEK 2 (bioMérieux) and MicroScan (Siemens, USA) for identification of Acinetobacter BSI isolates. Methods: A total of 187 BSI isolates recovered at a university hospital in Korea between 2010 and 2012 were analyzed. The identification results obtained using VITEK MS and two automated systems were compared with those of rpoB sequencing. Results: Of 187 isolates analyzed, 176 were identified to the species level by rpoB sequencing: the Acinetobacter baumannii group (ABG; 101 A. baumannii, 43 A. nosocomialis, 10 A. pittii isolates) was most commonly identified (82.4%), followed by Acinetobacter genomic species 13BJ/14TU (5.3%), A. ursingii (2.1%), A. soli (2.1%), A. bereziniae (1.1%), and A. junii (1.1%). Correct identification rates to the species group (ABG) level or the species level was comparable among the three systems (VITEK MS, 90.3%; VITEK 2, 89.2%; MicroScan, 86.9%). However, VITEK MS generated fewer misidentifications (0.6%) than VITEK 2 (10.8%) and MicroScan (13.1%) (P<0.001). In addition, VITEK MS demonstrated higher specificity (100%) for discrimination between ABG and non-ABG isolates than the other systems (both, 31.8%) (P<0.001). Conclusions: The VITEK MS system is superior to the VITEK 2 and MicroScan systems for identification of Acinetobacter BSI isolates, with fewer misidentifications and better discrimination between the ABG and non-ABG isolates.
참고문헌 (24)
- Chuang YC, "Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia", Clin Infect Dis, 52, pp.352~360 (2011)
- Peleg AY, "Acinetobacter baumannii: emergence of a successful pathogen", Clin Microbiol Rev, 21, pp.538~582 (2008)
- Turton JF, "Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species", J Clin Microbiol, 48, pp.1445~1449 (2010)
- Karah N, "Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway", J Antimicrob Chemother, 66, pp.738~744 (2011)
- Dijkshoorn L, "An increasing threat in hospitals : multidrug-resistant Acinetobacter baumannii", Nat Rev Microbiol, 5, pp.939~951 (2007)
- 김두운, "Acinetobacter soli sp. nov., Isolated from Forest Soil", The Journal of Microbiology, 46(4), pp.396~401 (2008), 한국미생물학회
- Nemec A, "Acinetobacter beijerinckii sp. nov. and gyllenbergii sp. nov., haemolytic organisms isolated from humans", Int J Syst Evol Microbiol, 59, pp.118~124 (2009)
- Vaneechoutte M, "Reclassification of Acinetobacter grimontii Carr et al. 2003 as a later synonym of Acinetobacter junii Bouvet and Grimont 1986", Int J Syst Evol Microbiol, 58, pp.937~940 (2008)
- Wisplinghoff H, "Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States", J Infect, 64, pp.282~290 (2012)
- Kishii K, "Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for species identification of Acinetobacter strains isolated from blood cultures", Clin Microbiol Infect, 20, pp.424~430 (2014)
- Lee SY, "Identification, genotypic relation, and clinical features of colistin-resistant isolates of Acinetobacter genomic species 13BJ", 14TU from bloodstreams of patients in a university hospital, 2014, pp.52, 931~939
- Lee YC, "Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcome", J Antimicrob Chemother, 66, pp.1839~1846 (2011)
- 이경원, "Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens", Yonsei Medical Journal, 52(6), pp.879~891 (2011), 연세대학교의과대학
- Bernards AT, "Evaluation of the ability of a commercial system to identify Acinetobacter genomic species", Eur J Clin Microbiol Infect Dis, 15, pp.303~308 (1996)
- Dubois D, "Performances of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology", J Clin Microbiol, 50, pp.2568~2576 (2012)
- Manji R, "Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli", Eur J Clin Microbiol Infect Dis, 33, pp.337~346 (2014)
- Khamis A, "rpoB gene sequencing for identification of Corynebacterium species", J Clin Microbiol, 42, pp.3925~3931 (2004)
- La Scola B, "Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species", J Clin Microbiol, 44, pp.827~832 (2006)
- Gundi VA, "Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species", Microbiology, 155, pp.2333~2341 (2009)
- Won EJ, "Accuracy of species-level identification of yeast isolates from blood cultures from 10 university hospitals in South Korea by use of the matrix-assisted laser desorption ionization-time of flight mass spectrometry-based Vitek MS system", J Clin Microbiol, 51, pp.3063~3065 (2013)
- Gerner-Smidt P, "Reliability of phenotypic tests for identification of Acinetobacter species", J Clin Microbiol, 29, pp.277~282 (1991)
- Seifert H, "Bacteremia due to Acinetobacter species other than Acinetobacter baumannii", Infection, 22, pp.379~385 (1994)
- Wareham DW, "Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance", Eur J Clin Microbiol Infect Dis, 27, pp.607~612 (2008)
- Šedo O, "Improvement of MALDI-TOF MS profiling for the differentiation of species within the Acinetobacter calcoaceticus-Acinetobacter baumannii complex", Syst Appl Microbiol, 36, pp.572~578 (2013)